Equities

Daiken Medical Co Ltd

7775:TYO

Daiken Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)546.00
  • Today's Change0.00 / 0.00%
  • Shares traded60.80k
  • 1 Year change+5.61%
  • Beta0.5284
Data delayed at least 20 minutes, as of Jul 05 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Company’s products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.

  • Revenue in JPY (TTM)9.75bn
  • Net income in JPY988.60m
  • Incorporated1968
  • Employees175.00
  • Location
    Daiken Medical Co Ltd2-6-2, AyuminoIZUMI-SHI 594-1157JapanJPN
  • Phone+81 725303150
  • Fax+81 662319902
  • Websitehttps://daiken-iki.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Create Medic Co Ltd12.69bn83.34m9.33bn962.00105.110.574813.510.73489.189.181,395.571,678.910.66781.734.3913,193,190.000.43853.000.51453.5343.6845.360.65674.602.98--0.050363.222.103.11-68.06-25.530.66271.12
DVx Inc45.85bn172.91m10.78bn316.0060.221.1417.810.235116.6116.614,394.81880.721.9826.604.02145,098,300.000.74743.111.777.5710.3911.600.37711.491.51--0.001447.57-3.442.57-81.53-29.2311.2315.81
EcoNaviSta Inc1.17bn273.12m12.64bn35.0052.793.9842.7210.7837.3837.38175.91495.790.46881.689.5033,514,490.0010.92--12.19--65.00--23.28--11.53--0.00--21.55--38.02------
OLBA Healthcare Holdings Inc117.02bn1.50bn12.67bn1.32k8.091.116.190.1083250.44250.4419,539.551,826.782.6616.204.3288,854,800.003.402.7112.139.7811.5811.061.280.91740.9764152.760.162732.162.330.5165-7.896.06-6.4211.84
JMS Co Ltd65.29bn-36.00m13.21bn5.28k--0.32223.600.2023-1.49-1.492,668.181,657.260.82072.784.0712,358,890.00-0.05781.33-0.08651.9721.5924.29-0.07051.570.987-89.330.397943.312.432.38-112.81---2.421.22
Techno Medica Co Ltd10.28bn1.35bn15.93bn237.0010.010.909510.901.55181.53181.531,319.311,998.920.55772.552.6543,391,780.007.316.688.787.8050.1048.8613.1112.313.85--0.0039.339.781.9617.154.190.71687.67
Kusurinomadoguchi Inc8.72bn870.92m16.76bn505.0018.332.638.781.9283.2483.24841.21580.15------17,270,220.00--------56.56--10.03----898.950.4574--17.53--122.49------
Seed Co Ltd32.40bn1.96bn16.92bn962.007.270.97473.530.522276.9476.941,276.55573.500.72332.657.4833,676,460.004.381.997.533.5143.7842.316.062.740.8037--0.578139.565.891.90721.4415.3020.424.56
Daiken Medical Co Ltd9.75bn988.60m17.45bn175.0015.922.2414.511.7934.4134.41339.39244.440.88563.914.0355,715,240.008.987.4412.9110.8440.8441.7410.149.281.58752.550.231571.356.713.0138.843.03-4.010.9806
HOSHI IRYO-SANKI CO., LTD14.78bn1.40bn17.48bn486.0011.340.93227.571.18450.70450.704,742.975,481.600.667434.485.3530,407,840.006.375.668.077.1948.7849.049.558.652.86--0.045816.347.256.4212.0110.04-13.238.45
Japan Medical Dynamic Marketing, INC.23.18bn1.27bn17.98bn511.0014.060.70096.200.775648.3048.30880.53968.740.76090.68154.1545,357,630.004.296.514.927.5363.6966.975.638.882.11--0.055218.338.786.74-10.68-8.52-2.959.24
Medius Holdings Co Ltd250.78bn847.94m19.64bn2.29k23.040.98887.560.078338.5138.5111,407.31897.032.2717.994.25109,607,600.000.76731.643.176.0212.0511.490.33810.58370.899338.740.565731.155.497.29-19.8015.0942.529.46
Medical Data Vision Co Ltd6.25bn688.02m24.38bn262.0033.815.8432.243.9018.0118.01163.57104.341.15282.077.8423,847,790.0012.1816.1617.0120.8877.4381.9010.5515.522.7213.480.0019.985.1512.4012.4869.75-23.95--
Data as of Jul 05 2024. Currency figures normalised to Daiken Medical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

3.37%Per cent of shares held by top holders
HolderShares% Held
SBI Asset Management Co., Ltd.as of 22 Jul 2022334.00k1.05%
Dimensional Fund Advisors LPas of 06 Jun 2024236.10k0.74%
Nomura Asset Management Co., Ltd.as of 31 May 2024178.50k0.56%
Nikko Asset Management Co., Ltd.as of 07 Jun 202485.60k0.27%
Daiwa Asset Management Co. Ltd.as of 31 May 202480.40k0.25%
Bessemer Investment Management LLCas of 31 Jan 202451.10k0.16%
Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Jun 202437.30k0.12%
Norges Bank Investment Managementas of 31 Dec 202329.90k0.09%
BlackRock Japan Co. Ltd.as of 06 Jun 202426.40k0.08%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 19 Feb 202414.00k0.04%
More ▼
Data from 22 Jun 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.